Browse diseases

…herapy offers a promising strategy for treating a wide range of hematologic and solid malignancies. However, the current challenge is to establish a robust, scala…

…> 100), CrCl (53%, median 45), platelet count (50%, median 75), autoimmune disease (47%), hemoglobin (39%, median 8), and age (13%, median 75).At …